ACO Name and Location
Orlando Health Collaborative Care
1414 Kuhl Ave. MP2
Orlando, Florida 32806
ACO Primary Contact
|
Primary Contact Name |
Robyn Bartek |
|
Primary Contact Phone Number |
321.843.8366 |
|
Primary Contact Email Address |
Organizational Information
ACO participants:
|
ACO Participants |
ACO Participant in Joint Venture (Enter Y or N) |
|
West Orange Physicians Group, LLC |
N |
|
Orlando Health, Inc. |
N |
|
Orlando Physicians Network, Inc |
N |
|
Orlando Health Physician Group, Inc. |
N |
|
South Lake Hospital, Inc. |
N |
|
Physician Associates, LLC |
N |
ACO governing body:
|
Member |
Member's Voting Power |
Membership Type |
ACO Participant TIN Legal Business Name/DBA, if Applicable |
||
|
Last Name |
First Name |
Title/Position |
|||
|
Senne |
Jerry |
Executive Director |
1 |
ACO Participant Representative |
Orlando Health |
|
Spong |
Bernadette |
Chief Financial Officer, Orlando Health |
1 |
ACO Participant Representative |
Orlando Health |
|
Burket |
Brandon |
AVP, Value Based Care & Population Health |
1 |
ACO Participant Representative |
Orlando Health |
|
Walker |
Erik |
MD |
1 |
ACO Participant Representative |
Orlando Health Physician Associates |
|
Kaplan |
Benjamin |
MD |
1 |
ACO Participant Representative |
Orlando Physicians Network |
|
Jackson |
Amy |
MD |
1 |
ACO Participant Representative |
West Orange Physician Group |
|
Soto |
Martin |
MD |
1 |
ACO Participant Representative |
Orlando Health Physician Associates |
|
Desai |
Sunil |
MD |
1 |
ACO Participant Representative |
Orlando Health Physician Group, Inc. |
|
MacDiarmid |
Malcolm |
|
1 |
Medicare Beneficiary Representative |
|
Key ACO clinical and administrative leadership:
|
Jerry Senne |
ACO Executive |
|
Martin Soto |
Medical Director |
|
Dave Huddleson |
Compliance Officer |
|
Benjamin Kaplan |
Quality Assurance/Improvement Officer |
Associated committees and committee leadership:
|
Committee Name |
Committee Leader Name and Position |
|
Quality Improvement and Care Coordination |
Benjamin Kaplan, MD, Chair |
|
Finance and Operations |
Erik Walker, MD, Chair |
|
Compliance |
David Huddleson, Chair |
|
|
|
Types of ACO participants, or combinations of participants, that formed the ACO:
- ACO professionals in a group practice arrangement
- Hospital employing ACO professionals
- Partnerships or joint venture arrangements between hospitals and ACO professionals
Shared Savings and Losses
First Agreement Period
- Performance Year 2019, $ 1,689,626
Shared Savings Distribution:
First Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: 20%
- Proportion invested in redesigned care processes/resources: 40%
- Proportion of distribution to ACO participants: 40%
Quality Performance Results
2019 Quality Performance Results:
|
ACO # |
Measure Name |
Rate |
ACO Mean |
|
ACO-1 |
CAHPS: Getting Timely Care, Appointments, and Information |
85.85 |
85.86 |
|
ACO-2 |
CAHPS: How Well Your Providers Communicate |
95.20 |
94.11 |
|
ACO-3 |
CAHPS: Patients’ Rating of Provider |
94.85 |
92.69 |
|
ACO-4 |
CAHPS: Access to Specialists |
83.92 |
81.54 |
|
ACO-5 |
CAHPS: Health Promotion and Education |
62.37 |
60.44 |
|
ACO-6 |
CAHPS: Shared Decision Making |
60.93 |
62.78 |
|
ACO-7 |
CAHPS: Health Status/Functional Status |
74.52 |
73.79 |
|
ACO-34 |
CAHPS: Stewardship of Patient Resources |
29.59 |
26.17 |
|
ACO-45 |
CAHPS: Courteous and Helpful Office Staff |
94.74 |
92.84 |
|
ACO-46 |
CAHPS: Care Coordination |
86.72 |
86.89 |
|
ACO-8 |
Risk Standardized, All Condition Readmission |
15.14 |
14.86 |
|
ACO-38 |
All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions |
57.63 |
58.15 |
|
ACO-43 |
Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI) #91) |
1.71 |
1.87 |
|
ACO-13 |
Falls: Screening for Future Fall Risk |
93.07 |
84.04 |
|
ACO-14 |
Preventive Care and Screening: Influenza Immunization |
82.98 |
74.77 |
|
ACO-17 |
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention |
37.50 |
78.04 |
|
ACO-18 |
Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan |
62.36 |
70.40 |
|
ACO-19 |
Colorectal Cancer Screening |
81.51 |
70.76 |
|
ACO-20 |
Breast Cancer Screening |
75.17 |
73.84 |
|
ACO-42 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
84.16 |
82.17 |
|
ACO-27 |
Diabetes Mellitus: Hemoglobin A1c Poor Control |
8.05 |
13.88 |
|
ACO-28 |
Hypertension (HTN): Controlling High Blood Pressure |
71.18 |
75.04 |
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.
For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.
Payment Rule Waivers
- Yes, our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR 425.612.
